Tonix Pharmaceuticals Holding Corp Dividends
The next dividend date for Tonix Pharmaceuticals Holding Corp has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Tonix Pharmaceuticals Holding Corp (TNXP)
More About Tonix Pharmaceuticals Holding Corp
Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. Its portfolio focuses on central nervous system disorders, as well as immunology, infectious disease, and rare disease product candidates. The company's products pipeline include TNX-102 SL (cyclobenzaprine HCl sublingual tablet), for the management of fibromyalgia; and is being developed to prevent and treat acute stress reaction, posttraumatic stress disorder, Alzheimer's disease, alcohol use disorder, and multi-site pain associated with Long COVID. It also develops TNX-1300, a double-mutant cocaine esterase, which is in Phase 2 clinical trials for the treatment of cocaine intoxication; and TNX-1900, an intranasal potentiated oxytocin for the treatment of binge eating disorder, adolescent obesity, and bone health in pediatric autism, as well as for social anxiety disorder. In addition, the company develops TNX-1500, an Fc-modified humanized monoclonal antibody indicated to prevent organ transplant rejection, as well as to treat autoimmune conditions; TNX-1700, a recombinant Trefoil Factor Family 2 fusion protein for the treatment of gastric and colorectal cancers; TNX-801 that is in the pre-IND development stage for protection against smallpox and mpox; and TNX-1800, a live virus vaccine for SARS-CoV-2. Its rare disease portfolio consists of TNX-2900, an intranasal potentiated oxytocin to treat for Prader-Willi syndrome. The company has collaboration agreement with Bilthoven Biologicals to advance TNX-801 and Makana Therapeutics, Inc. to study TNX-1500 for human-compatible organs and cells for the treatment of organ failure. Tonix Pharmaceuticals Holding Corp. is headquartered in Chatham, New Jersey.
Owning Tonix Pharmaceuticals Holding Corp Stock on the Dividend Date
If you own Tonix Pharmaceuticals Holding Corp stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Tonix Pharmaceuticals Holding Corp stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Tonix Pharmaceuticals Holding Corp stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Tonix Pharmaceuticals Holding Corp stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Tonix Pharmaceuticals Holding Corp dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Tonix Pharmaceuticals Holding Corp Dividends
You can contact us any time if you would like to ask questions about Tonix Pharmaceuticals Holding Corp dividends or anything else related to the stock market.